Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 3, 2011, Pages 470-479

  Maeda, Megumi ^a   Nishimura, Yasumitsu ^a   Hayashi, Hiroaki ^a   Kumagai, Naoko ^a   Chen, Ying ^a   Murakami, Shuko ^a   Miura, Yoshie ^b   Hiratsuka, Jun Ichi ^a   Kishimoto, Takumi ^c   Otsuki, Takemi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c OKAYAMA ROSAI HOSPITAL   (Japan)

Author keywords

Asbestos; CXCR3; IFN ; Malignant mesothelioma

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CHRYSOTILE; GAMMA INTERFERON;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE STATUS; IMMUNOPATHOLOGY; IN VITRO STUDY; LONG TERM EXPOSURE; NUCLEOTIDE SEQUENCE; RECEPTOR DOWN REGULATION; T LYMPHOCYTE;

APOPTOSIS; ASBESTOS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CLUSTER ANALYSIS; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNE SYSTEM; INTERFERON-GAMMA; LUNG NEOPLASMS; MESOTHELIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CXCR3; T-LYMPHOCYTES;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 80052530623     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0213OC     Document Type: Article

References (42)

1. Pan X.L., Day H.W., Wang W., Beckett L.A., Schenker M.B. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 2005;172:1019-1025. (Pubitemid 41476540)
2. Cugell D.W., Kamp D.W. Asbestos and the pleura: A review. Chest 2004;125:1103-1117. (Pubitemid 38367306)
3. Miserocchi G., Sancini G., Mantegazza F., Chiappino G. Translocation pathways for inhaled asbestos fibers. Environ Health 2008;7:4.
4. Murayama T., Takahashi K., Natori Y., Kurumatani N. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med 2006;49:1-7. (Pubitemid 43083291)
5. Upadhyay D., Kamp D.W. Asbestos-induced pulmonary toxicity: Role of DNA damage and apoptosis. Exp Biol Med (Maywood) 2003;228:650-659. (Pubitemid 37163254)
6. Panduri V., Surapureddi S., Soberanes S., Weitzman S.A., Chandel N., Kamp D.W. P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis. Am J Respir Cell Mol Biol 2006;34:443-452.
7. Upadhyay D., Panduri V., Kamp D.W. Fibroblast growth factor-10 prevents asbestos-induced alveolar epithelial cell apoptosis by a mitogen-activated protein kinase-dependent mechanism. Am J Respir Cell Mol Biol 2005;32:232-238. (Pubitemid 40387650)
8. Mossman B.T. Introduction to serial reviews on the role of reactive oxygen and nitrogen species (ROS/RNS) in lung injury and diseases. Free Radic Biol Med 2003;34:1115-1116. (Pubitemid 36423361)
9. Kamp D.W., Panduri V., Weitzman S.A., Chandel N. Asbestos-induced alveolar epithelial cell apoptosis: Role of mitochondrial dysfunction caused by iron-derived free radicals. Mol Cell Biochem 2002;234-235:153-160. (Pubitemid 34777852)
10. Jiang L., Nagai H., Ohara H., Hara S., Tachibana M., Hirano S., Shinohara Y., Kohyama N., Akatsuka S., Toyokuni S. Characteristics and modifying factors of asbestos-induced oxidative DNA damage. Cancer Sci 2008;99:2142-2151.
11. Nishimura Y., Miura Y., Maeda M., Kumagai N., Murakami S., Hayashi H., Fukuoka K., Nakano T., Otsuki T. Impairment in cytotoxicity and expression of NK cell-activating receptors on human NK cells following exposure to asbestos fibers. Int J Immunopathol Pharmacol 2009;22:579-590.
12. Nishimura Y., Maeda M., Kumagai N., Hayashi H., Miura Y., Otsuki T. Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos. Int J Immunopathol Pharmacol 2009;22:879-888.
13. Ueki A., Yamaguchi M., Ueki H., Watanabe Y., Ohsawa G., Kinugawa K., Kawakami Y., Hyodoh F. Polyclonal human T-cell activation by silicate in vitro. Immunology 1994;82:332-335. (Pubitemid 24241752)
14. Aikoh T., Tomokuni A., Matsukii T., Hyodoh F., Ueki H., Otsuki T., Ueki A. Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silicate in vitro. Int J Oncol 1998;12:1355-1359. (Pubitemid 28239949)
15. Miyoshi I., Kubonishi I., Yoshimoto S., Shiraishi Y. A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells. Gann 1981;72:978-981. (Pubitemid 12172471)
16. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981;294:770-771. (Pubitemid 12174453)
17. Miura Y., Nishimura Y., Katsuyama H., Maeda M., Hayashi H., Dong M., Hyodoh F., Tomita M., Matsuo Y., Uesaka A., et al. Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells. Apoptosis 2006;11:1825-1835. (Pubitemid 44371055)
18. Hyodoh F., Takata-Tomokuni A., Miura Y., Sakaguchi H., Hatayama T., Hatada S., Katsuyama H., Matsuo Y., Otsuki T. Inhibitory effects of antioxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A. Scand J Immunol 2005;61:442-448. (Pubitemid 40695015)
19. Maeda M., Miura Y., Nishimura Y., Murakami S., Hayashi H., Kumagai N., Hatayama T., Katoh M., Miyahara N., Yamamoto S., et al. Immunological changes in mesothelioma patients and their experimental detection. Clin Med Insights Circ Respir Pulmon Med 2008;2:11-17.
20. Nishimura Y., Miura Y., Maeda M., Hayashi H., Dong M., Katsuyama H., Tomita M., Hyodoh F., Kusaka M., Uesaka A., et al. Expression of the T cell receptor Vbeta repertoire in a human T cell resistant to asbestos-induced apoptosis and peripheral blood T cells from patients with silica and asbestos-related diseases. Int J Immunopathol Pharmacol 2006;19:795-805. (Pubitemid 46145043)
21. Kohyama N., Shinohara Y., Suzuki Y. Mineral phases and some reexamined characteristics of the International Union against Cancer standard asbestos samples. Am J Ind Med 1996;30:515-528. (Pubitemid 26375174)
22. Luster A.D., Leder P. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med 1993;178:1057-1065. (Pubitemid 23260444)
23. Abraham J.L. Recent advances in pneumoconiosis: The pathologist's role in etiologic diagnosis. Monogr Pathol 1978;19:96-137.
24. Vallyathan N.V., Green F.H., Craighead J.E. Recent advances in the study of mineral pneumoconiosis. Pathol Annu 1980;15:77-104.
25. Begin R., Cantin A., Masse S. Recent advances in the pathogenesis and clinical assessment of mineral dust pneumoconioses: Asbestosis, silicosis and coal pneumoconiosis. Eur Respir J 1989;2:988-1001. (Pubitemid 20019758)
26. Scheule R.K., Holian A. Immunologic aspects of pneumoconiosis. Exp Lung Res 1991;17:661-685.
27. Uber C.L., McReynolds R.A. Immunotoxicology of silica. Crit Rev Toxicol 1982;10:303-319.
28. Steenland K., Goldsmith D.F. Silica exposure and autoimmune diseases. Am J Ind Med 1995;28:603-608.
29. Kannerstein M., Churg J., McCaughey W.T. Asbestos and mesothelioma: A review. Pathol Annu 1978;13:81-129.
30. Kannerstein M., Churg J., McCaughey E., Selikoff I.J. Pathogenic effects of asbestos. Arch Pathol Lab Med 1977;101:623-628. (Pubitemid 8249453)
31. Craighead J.E., Mossman B.T. The pathogenesis of asbestos-associated diseases. N Engl J Med 1982;306:1446-1455. (Pubitemid 12121576)
32. Otsuki T., Miura Y., Nishimura Y., Hyodoh F., Takata A., Kusaka M., Katsuyama H., Tomita M., Ueki A., Kishimoto T. Alterations of Fas and Fas-related molecules in patients with silicosis. Exp Biol Med (Maywood) 2006;231:522-533.
33. Otsuki T., Maeda M., Murakami S., Hayashi H., Miura Y., Kusaka M., Nakano T., Fukuoka K., Kishimoto T., Hyodoh F., et al. Immunological effects of silica and asbestos. Cell Mol Immunol 2007;4:261-268.
34. Wu P., Hyodoh F., Hatayama T., Sakaguchi H., Hatada S., Miura Y., Takata-Tomokuni A., Katsuyama H., Otsuki T. Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos/chrysotile-A. Immunol Lett 2005;98:145-152. (Pubitemid 40409830)
35. Wu P., Miura Y., Hyodoh F., Nishimura Y., Hatayama T., Hatada S., Sakaguchi H., Kusaka M., Katsuyama H., Tomita M., et al. Reduced function of CD41251 regulatory T cell fraction in silicosis patients. Int J Immunopathol Pharmacol 2006;19:357-368. (Pubitemid 44181958)
36. Pooley F.D. Mineralogy of asbestos: The physical and chemical properties of the dusts they form. Semin Oncol 1981;8:243-249. (Pubitemid 11021513)
37. Stephens M., Gibbs A.R., Pooley F.D., Wagner J.C. Asbestos induced diffuse pleural fibrosis: Pathology and mineralogy. Thorax 1987;42:583-588. (Pubitemid 17125998)
38. Rudge G., Barrett S.P., Scott B., Van Driel I.R. Infiltration of a mesothelioma by IFN-gamma-producing cells and tumor rejection after depletion of regulatory T cells. J Immunol 2007;178:4089-4096. (Pubitemid 46492357)
39. Miller C.H., Maher S.G., Young H.A. Clinical use of interferon-gamma. Ann N Y Acad Sci 2009;1182:69-79.
40. Rotondi M., Chiovato L., Romagnani S., Serio M., Romagnani P. Role of chemokines in endocrine autoimmune diseases. Endocr Rev 2007;28:492-520. (Pubitemid 47236335)
41. Luther S.A., Cyster J.G. Chemokines as regulators of T cell differentiation. Nat Immunol 2001;2:102-107. (Pubitemid 33707926)
42. Loetscher M., Loetscher P., Brass N., Meese E., Moser B. Lymphocyte-specific chemokine receptor CXCR3: Regulation, chemokine binding and gene localization. Eur J Immunol 1998;28:3696-3705. (Pubitemid 28510780)